Overall, the stimulation of CD4+ T cells by UCPVax vaccination resulted in three main types of immune responses, including cytokine polyF Th1 cells, helper humoral immunity, and epitope spreading in patients with NSCLC. Here, CD4 is linked to non-small cell lung carcinoma.